DK2255791T3 - Forlænget-frigivelse-farmaceutisk sammensætning omfattende metoprololsuccinat - Google Patents

Forlænget-frigivelse-farmaceutisk sammensætning omfattende metoprololsuccinat

Info

Publication number
DK2255791T3
DK2255791T3 DK09159296.4T DK09159296T DK2255791T3 DK 2255791 T3 DK2255791 T3 DK 2255791T3 DK 09159296 T DK09159296 T DK 09159296T DK 2255791 T3 DK2255791 T3 DK 2255791T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
metoprolol succinate
extended
release pharmaceutical
pharmaceutically acceptable
Prior art date
Application number
DK09159296.4T
Other languages
English (en)
Inventor
Chitra Shah
Francisco Gual-Pujol
Joaquim Amela-Navarro
Jose Luis Ruiz-Cordoba
Original Assignee
Zaklady Farmaceutyczne Polpharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zaklady Farmaceutyczne Polpharma Sa filed Critical Zaklady Farmaceutyczne Polpharma Sa
Application granted granted Critical
Publication of DK2255791T3 publication Critical patent/DK2255791T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
DK09159296.4T 2009-04-03 2009-05-04 Forlænget-frigivelse-farmaceutisk sammensætning omfattende metoprololsuccinat DK2255791T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09157343 2009-04-03

Publications (1)

Publication Number Publication Date
DK2255791T3 true DK2255791T3 (da) 2012-03-05

Family

ID=45217821

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09159296.4T DK2255791T3 (da) 2009-04-03 2009-05-04 Forlænget-frigivelse-farmaceutisk sammensætning omfattende metoprololsuccinat

Country Status (5)

Country Link
US (1) US20100255105A1 (da)
EP (1) EP2255791B1 (da)
AT (1) ATE533475T1 (da)
DK (1) DK2255791T3 (da)
PL (1) PL2255791T3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012052834A2 (en) * 2010-10-21 2012-04-26 Inventia Healthcare Private Limited Multiple unit particulate system comprising metoprolol succinate

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE457505B (sv) 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
EP1589957A1 (en) * 2003-02-05 2005-11-02 IPCA Laboratories Limited Pharmaceutical compositions and process of production thereof
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20090247642A1 (en) * 2005-12-23 2009-10-01 Carmen Arnalot Aguilar Synthesis and preparations of metoprolol and its salts
CA2642340A1 (en) * 2006-02-24 2007-08-30 Teva Pharmaceutical Industries Ltd. Metoprolol succinate e.r. tablets and methods for their preparation
WO2008012346A1 (en) * 2006-07-28 2008-01-31 Farmaprojects, S. A. Extended release pharmaceutical formulation of metoprolol and process for its preparation

Also Published As

Publication number Publication date
US20100255105A1 (en) 2010-10-07
EP2255791B1 (en) 2011-11-16
EP2255791A1 (en) 2010-12-01
PL2255791T3 (pl) 2012-05-31
ATE533475T1 (de) 2011-12-15

Similar Documents

Publication Publication Date Title
NL300871I2 (nl) ixazomib en farmaceutisch aanvaardbare zouten en esters daarvan, zoals ixazomibcitraat
CL2007002018A1 (es) Compuestos derivados de isoxazolinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de una enfermedad causada por un aumento en la proliferacion celular.
TN2009000093A1 (en) Pharmaceutical compositions comprising nilotinib or its salt
IL201796A (en) Indole-3-Inglet or its pharmaceutical salts for use in the treatment of dermal lesion caused by papillomavirus
IL214942A (en) N, n– Dimethyl-5– (2-methyl-6 - ((5-methylpyrazine-2-yl) carbamole) Benzoporen-4-Iloxy) Pyrimidine-2-carboxamide and the salts common in its pharmacies, pharmaceuticals containing them and their uses in the preparation of drugs
WO2006082523A3 (en) Pharmaceutical sustained release composition of metformin
ATE540680T1 (de) Pharmazeutische aripiprazol-zusammensetzungen
WO2009063222A3 (en) Solid compositions
MY153921A (en) Aminopyrazole derivatives
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
IN2012DN03337A (da)
NZ598427A (en) Stabilized amorphous forms of imatinib mesylate with cyclodextrin complex
NI201100227A (es) Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica.
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
WO2012087255A3 (en) Pharmaceutical formulations comprising imatinib
WO2013106068A3 (en) Therapeutic compositions of specified herbal formulations and uses thereof
CL2015001615A1 (es) Una composicion farmaceutica que comprende vortioxetina y donepezilo junto con un excipiente farmaceuticamente aceptable; y su uso para el tratamiento de disfuncion cognitiva, demencia en la enfermedad de alzheimer, disfuncion cognitiva asociada a la depresion y a la esquizofrenia, entre otras enfermedades.
MY161749A (en) Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
DE602008002371D1 (de) Pharmazeutische zusammensetzung mit candesartan-cilexetil
BRPI0821454A2 (pt) Formulação farmacêutica, excipiente para a preparação de formulação farmacêuticas de liberação lenta, e, processos para a produção de um excipiente de liberação lenta, e de uma forma farmacêutica.
DK2255791T3 (da) Forlænget-frigivelse-farmaceutisk sammensætning omfattende metoprololsuccinat
WO2010149794A3 (en) Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
WO2009053654A3 (fr) Prodrogues phosphoesters de la gemcitabine comme agents anticancereux